Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bioventus (BVS) Cash from Investing Activities (2020 - 2026)

Bioventus filings provide 6 years of Cash from Investing Activities readings, the most recent being -$580000.0 for Q4 2025.

  • On a quarterly basis, Cash from Investing Activities fell 102.41% to -$580000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was -$3.2 million, a 114.14% decrease, with the full-year FY2025 number at -$3.2 million, down 114.14% from a year prior.
  • Cash from Investing Activities hit -$580000.0 in Q4 2025 for Bioventus, down from -$473000.0 in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $48.5 million in Q4 2022 to a low of -$221.3 million in Q4 2021.
  • Median Cash from Investing Activities over the past 5 years was -$1.2 million (2024), compared with a mean of -$18.2 million.
  • Biggest five-year swings in Cash from Investing Activities: plummeted 12832.67% in 2021 and later skyrocketed 467.87% in 2022.
  • Bioventus' Cash from Investing Activities stood at -$221.3 million in 2021, then surged by 51.08% to -$108.2 million in 2022, then skyrocketed by 88.82% to -$12.1 million in 2023, then surged by 299.26% to $24.1 million in 2024, then plummeted by 102.41% to -$580000.0 in 2025.
  • The last three reported values for Cash from Investing Activities were -$580000.0 (Q4 2025), -$473000.0 (Q3 2025), and -$1.4 million (Q2 2025) per Business Quant data.